-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Prognostication and risk stratification strategies for patients with myelodysplastic syndromes

Program: Marquee Sessions
Session: ASH-EHA Joint Symposium
Sunday, December 8, 2024, 12:30 PM-1:30 PM

Amy E. DeZern, MD, MHS

Johns Hopkins University, Baltimore, MD; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD

Disclosures: DeZern: servier: Membership on an entity's Board of Directors or advisory committees; Keros: Membership on an entity's Board of Directors or advisory committees; Shattuck Labs: Membership on an entity's Board of Directors or advisory committees; Appellis: Membership on an entity's Board of Directors or advisory committees; geron: Other: dsmb; Bristol Myers Squibbs: Membership on an entity's Board of Directors or advisory committees; Astellas: Honoraria.

See more of: ASH-EHA Joint Symposium
See more of: Marquee Sessions
<< Previous Presentation | Next Presentation